| scholarly article | Q13442814 |
| P2093 | author name string | D M Margolis | |
| F Romerio | |||
| J J Coull | |||
| J L Volker | |||
| J M Sun | |||
| J R Davie | |||
| K M Galvin | |||
| U Hansen | |||
| Y Shi | |||
| P2860 | cites work | Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein | Q24309481 |
| Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators | Q24309765 | ||
| Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site | Q24313121 | ||
| One exon of the human LSF gene includes conserved regions involved in novel DNA-binding and dimerization motifs | Q24314751 | ||
| Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex | Q24320470 | ||
| Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex | Q24324026 | ||
| Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro | Q24324378 | ||
| Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter | Q24523709 | ||
| Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1 | Q24562189 | ||
| Molecular cloning of the alpha-globin transcription factor CP2 | Q24630497 | ||
| Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production | Q24647800 | ||
| Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3 | Q24648290 | ||
| Repression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSF | Q24653519 | ||
| Transcriptional repression of the c-fos gene by YY1 is mediated by a direct interaction with ATF/CREB | Q24673119 | ||
| Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters | Q27936998 | ||
| Histone acetylation in chromatin structure and transcription | Q28131749 | ||
| What's up and down with histone deacetylation and transcription? | Q28238059 | ||
| Histone deacetylase activity is required for full transcriptional repression by mSin3A | Q28238079 | ||
| Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression | Q28238089 | ||
| Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family | Q28252866 | ||
| Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy | Q28253761 | ||
| Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc | Q28257537 | ||
| Retinoblastoma protein recruits histone deacetylase to repress transcription | Q28262144 | ||
| Retinoblastoma protein represses transcription by recruiting a histone deacetylase | Q28262155 | ||
| A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p | Q28276243 | ||
| The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3 | Q28276517 | ||
| Cyclophilin A and FKBP12 interact with YY1 and alter its transcriptional activity | Q28288097 | ||
| Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300 | Q28301874 | ||
| A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro | Q28306373 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase | Q29547913 | ||
| Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy | Q29615993 | ||
| Recovery of replication-competent HIV despite prolonged suppression of plasma viremia | Q29615995 | ||
| Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection | Q29619738 | ||
| Histone deacetylases: complex transducers of nuclear signals | Q33707422 | ||
| Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. | Q34057748 | ||
| Repression of HIV-1 transcription by a cellular protein | Q34092073 | ||
| Functional interactions between YY1 and adenovirus E1A. | Q34742589 | ||
| The zinc finger region of the adenovirus E1A transactivating domain complexes with the TATA box binding protein | Q35117818 | ||
| Histone acetyltransferases regulate HIV-1 enhancer activity in vitro | Q35199451 | ||
| New insights into chromatin function in transcriptional control | Q35595592 | ||
| Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. | Q35845347 | ||
| Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation | Q36685254 | ||
| trans-dominant mutants of E1A provide genetic evidence that the zinc finger of the trans-activating domain binds a transcription factor | Q36730508 | ||
| DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1 | Q36828450 | ||
| Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles | Q37459455 | ||
| Characterization of functional domains within the multifunctional transcription factor, YY1. | Q38287986 | ||
| Interaction between transcription factors Sp1 and YY1. | Q38315750 | ||
| Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus | Q38348287 | ||
| Transcriptional repression of eukaryotic promoters | Q38365817 | ||
| Relief of YY1-induced transcriptional repression by protein-protein interaction with the nucleolar phosphoprotein B23. | Q39485850 | ||
| Multiple mechanisms of transcriptional repression by YY1. | Q40022586 | ||
| Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region. | Q40116360 | ||
| An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. | Q40523037 | ||
| The price of repression | Q40541055 | ||
| Repression versus activation in the control of gene transcription | Q40731530 | ||
| Chromatin structure and RNA polymerase II connection: implications for transcription | Q40948234 | ||
| Chromatin unfolds | Q41021102 | ||
| Everything you have ever wanted to know about Yin Yang 1...... | Q41462866 | ||
| A bioassay for HIV-1 based on Env-CD4 interaction | Q41717006 | ||
| Preparation of extracts from higher eukaryotes | Q41981177 | ||
| Properties of chicken erythrocyte histone deacetylase associated with the nuclear matrix | Q42122077 | ||
| TATA-binding protein-independent initiation: YY1, TFIIB, and RNA polymerase II direct basal transcription on supercoiled template DNA. | Q42499091 | ||
| NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro | Q42513846 | ||
| Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. | Q42735234 | ||
| Autologous stimulation of YY1 transcription factor expression: role of an insulin-like growth factor | Q42830429 | ||
| Evidence that levels of the dimeric cellular transcription factor CP2 play little role in the activation of the HIV-1 long terminal repeat in vivo or following superinfection with herpes simplex virus type 1. | Q45780620 | ||
| Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters | Q46329660 | ||
| LSF and NTF-1 share a conserved DNA recognition motif yet require different oligomerization states to form a stable protein-DNA complex. | Q47827900 | ||
| Purification and characterization of chicken erythrocyte histone deacetylase 1. | Q47967003 | ||
| Covalent modifications of histones: expression from chromatin templates | Q48018634 | ||
| In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. | Q52050894 | ||
| 2 Purification of sequence-specific binding proteins by DNA affinity chromatography | Q67836408 | ||
| Transcription factor LSF binds two variant bipartite sites within the SV40 late promoter | Q68459469 | ||
| The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters | Q68646237 | ||
| Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding | Q71985007 | ||
| Mitogenic stimulation of resting T cells causes rapid phosphorylation of the transcription factor LSF and increased DNA-binding activity | Q73437044 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| virology | Q7215 | ||
| P304 | page(s) | 6790-6799 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. | |
| P478 | volume | 74 |
| Q34145909 | A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs |
| Q37192141 | A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression |
| Q34612737 | A prospective on drug abuse-associated epigenetics and HIV-1 replication. |
| Q63351215 | Activating Latent HIV by Inhibiting Bromodomain Proteins |
| Q92623251 | Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators |
| Q35015033 | An upstream YY1 binding site on the HIV-1 LTR contributes to latent infection |
| Q37348552 | Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo |
| Q37088793 | BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex |
| Q34032827 | BET bromodomain inhibition as a novel strategy for reactivation of HIV-1 |
| Q90594756 | Barriers for HIV Cure: The Latent Reservoir |
| Q35131533 | Binding of YY1 to the proximal region of the murine beta interferon promoter is essential to allow CBP recruitment and K8H4/K14H3 acetylation on the promoter region after virus infection |
| Q92637590 | Block-And-Lock Strategies to Cure HIV Infection |
| Q26829860 | Bromodomain proteins in HIV infection |
| Q99605171 | CBF-1 Promotes the Establishment and Maintenance of HIV Latency by Recruiting Polycomb Repressive Complexes, PRC1 and PRC2, at HIV LTR |
| Q42573954 | CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency |
| Q37196089 | Cellular reservoirs of HIV-1 and their role in viral persistence |
| Q39755194 | Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C. |
| Q95355768 | Chromatin Regulation and the Histone Code in HIV Latency |
| Q37589012 | Chromatin dynamics associated with HIV-1 Tat-activated transcription |
| Q37013167 | Chromatin, gene silencing and HIV latency |
| Q27021127 | Chromatin, non-coding RNAs, and the expression of HIV |
| Q36053057 | Coactivators in gene regulation by STAT5. |
| Q33877492 | Combinatorial latency reactivation for HIV-1 subtypes and variants |
| Q43564279 | Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses |
| Q41885967 | Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation |
| Q36839887 | Confronting proviral HIV infection |
| Q37972643 | Control of HIV latency by epigenetic and non-epigenetic mechanisms |
| Q33398516 | Control of stochastic gene expression by host factors at the HIV promoter |
| Q24537275 | Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat |
| Q37645582 | Curing HIV: Pharmacologic approaches to target HIV-1 latency |
| Q57795262 | Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors |
| Q39362365 | Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. |
| Q28111910 | Depletion of latent HIV-1 infection in vivo: a proof-of-concept study |
| Q39895237 | Determinants of the establishment of human immunodeficiency virus type 1 latency |
| Q37419972 | Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency |
| Q82815154 | Differential expression and interaction of host factors augment HIV-1 gene expression in neonatal mononuclear cells |
| Q42853053 | Disclosing the crosstalk among DNA methylation, transcription factors, and histone marks in human pluripotent cells through discovery of DNA methylation motifs |
| Q34816193 | Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system |
| Q37422505 | Dominant form of congenital hyperinsulinism maps to HK1 region on 10q. |
| Q35040154 | Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription |
| Q38096822 | Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials |
| Q40187559 | Epigenetic Metabolite Acetate Inhibits Class I/II Histone Deacetylases, Promotes Histone Acetylation, and Increases HIV-1 Integration in CD4+ T Cells |
| Q37015743 | Epigenetic control of cytomegalovirus latency and reactivation |
| Q36876345 | Epigenetic regulation of CD8(+) T-lymphocyte mediated suppression of HIV-1 replication |
| Q28475636 | Epigenetic regulation of HIV-1 latency by cytosine methylation |
| Q37643982 | Epigenetic regulation of HIV-1 latency in astrocytes |
| Q37962589 | Epigenetic regulation of HIV-1 transcription |
| Q30399588 | Eradication therapies for HIV Infection: time to begin again |
| Q33884209 | Erythroid cell-specific alpha-globin gene regulation by the CP2 transcription factor family |
| Q39783316 | Establishment and maintenance of HIV latency: model systems and opportunities for intervention |
| Q39712159 | Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction |
| Q36700634 | Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cycli |
| Q37719966 | Expression of TSG101 protein and LSF transcription factor in HPV-positive cervical cancer cells |
| Q24596282 | Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid |
| Q37257484 | Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors |
| Q38742404 | Extrachromosomal HPV-16 LCR transcriptional activation by HDACi opposed by cellular differentiation and DNA integration |
| Q28505491 | Genomic structure and analysis of transcriptional regulation of the mouse zinc-fingers and homeoboxes 1 (ZHX1) gene |
| Q35914266 | H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T Cells |
| Q37956178 | HDAC inhibitors in HIV. |
| Q46689072 | HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation |
| Q38271132 | HIV eradication: combinatorial approaches to activate latent viruses |
| Q37974218 | HIV latency |
| Q39109122 | HIV latency and integration site placement in five cell-based models. |
| Q36585019 | HIV latency: experimental systems and molecular models. |
| Q36121883 | HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide? |
| Q36552753 | HIV pharmacology: barriers to the eradication of HIV from the CNS. |
| Q40566982 | HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin. |
| Q34106191 | HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat |
| Q38206643 | HIV-1 latency in monocytes/macrophages |
| Q38204866 | HIV-1 latency: an update of molecular mechanisms and therapeutic strategies |
| Q37607912 | HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes |
| Q38667121 | HIV-Induced Epigenetic Alterations in Host Cells. |
| Q64253074 | HUSH, a Link Between Intrinsic Immunity and HIV Latency |
| Q45395775 | Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells |
| Q37123276 | High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects. |
| Q35784937 | High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms |
| Q34012255 | Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation |
| Q34816844 | Histone deacetylase inhibitors and HIV latency |
| Q35016964 | Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir |
| Q38019133 | Histone deacetylases in viral infections |
| Q34743301 | Histone-deacetylase inhibitors: novel drugs for the treatment of cancer |
| Q39616690 | Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells |
| Q37348467 | Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency |
| Q37922877 | Host factors mediating HIV-1 replication |
| Q36553171 | Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency |
| Q36330062 | Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication |
| Q91639383 | Human immunodeficiency virus type 1 transcription is regulated by thieno[3,4- d ]pyrimidine |
| Q36690000 | Identification of T cell-signaling pathways that stimulate latent HIV in primary cells |
| Q36483968 | Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response |
| Q26782046 | Impact of Chromatin on HIV Replication |
| Q36148507 | Impact of Tat Genetic Variation on HIV-1 Disease |
| Q41517609 | Impact of viral activators and epigenetic regulators on HIV-1 LTRs containing naturally occurring single nucleotide polymorphisms. |
| Q37051767 | In utero activation of fetal memory T cells alters host regulatory gene expression and affects HIV susceptibility |
| Q21245051 | In vitro nuclear interactome of the HIV-1 Tat protein |
| Q39749215 | In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection |
| Q92109292 | In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV+ individuals |
| Q80423703 | Induction of chromosomally integrated HIV-1 LTR requires RBF-2 (USF/TFII-I) and Ras/MAPK signaling |
| Q28581596 | Induction of the transcriptional repressor Yin Yang-1 by vascular cell injury. Autocrine/paracrine role of endogenous fibroblast growth factor-2 |
| Q42734211 | Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model |
| Q42770444 | Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells |
| Q34671609 | Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation. |
| Q93126280 | Insights into the HIV Latency and the Role of Cytokines |
| Q89685622 | Integrated assessment of viral transcription, antigen presentation, and CD8+ T cell function reveal multiple limitations of class I selective HDACi during HIV-1 latency reversal |
| Q34686713 | Interaction between endogenous bacterial flora and latent HIV infection |
| Q92344530 | Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines |
| Q37661770 | International AIDS Society global scientific strategy: towards an HIV cure 2016. |
| Q53219534 | Intrinsic disorder of human Yin Yang 1 protein. |
| Q33883423 | Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. |
| Q38071699 | Is specific HIV eradication from the brain possible or needed? |
| Q34371544 | LSF expression and its prognostic implication in colorectal cancer |
| Q30248766 | Latency reversal and viral clearance to cure HIV-1. |
| Q35962753 | Lineage-specific and ubiquitous biological roles of the mammalian transcription factor LSF |
| Q37010047 | Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation |
| Q38091888 | Lost in transcription: molecular mechanisms that control HIV latency |
| Q38212042 | Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages. |
| Q41825990 | Mammalian transcription factor LSF is a target of ERK signaling |
| Q37822089 | Mapping the architecture of the HIV-1 Tat circuit: A decision-making circuit that lacks bistability and exploits stochastic noise |
| Q33815611 | Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse |
| Q37738147 | Mechanisms of HIV latency: an emerging picture of complexity |
| Q42732128 | Mitogen-activated protein kinases regulate LSF occupancy at the human immunodeficiency virus type 1 promoter |
| Q36425963 | Multifunctional transcription factor YY1: a therapeutic target in human cancer? |
| Q47555946 | Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature |
| Q42128724 | NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation |
| Q36383606 | NF-κB/Rel: agonist and antagonist roles in HIV-1 latency |
| Q36645526 | NF45 and NF90 Bind HIV-1 RNA and Modulate HIV Gene Expression |
| Q28203103 | Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators |
| Q37151045 | Negative elongation factor (NELF) coordinates RNA polymerase II pausing, premature termination, and chromatin remodeling to regulate HIV transcription |
| Q45067800 | New Drugs in the Pipeline for the Treatment of HIV: a Review |
| Q39511336 | Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy. |
| Q33250088 | Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells |
| Q28257555 | Oncogenic potential of yin yang 1 mediated through control of imprinted genes |
| Q43226911 | Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. |
| Q37683398 | Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency |
| Q26797870 | Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus |
| Q58750447 | Post-translational Modification-Based Regulation of HIV Replication |
| Q39134670 | Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma. |
| Q42036532 | Proviral silencing in embryonic cells is regulated by Yin Yang 1. |
| Q35848096 | Quantitative evaluation and optimization of co-drugging to improve anti-HIV latency therapy |
| Q37041173 | Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling |
| Q39398757 | Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria |
| Q27013114 | Recent developments in human immunodeficiency virus-1 latency research |
| Q24294385 | Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing |
| Q24634457 | Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter |
| Q36887625 | Regulation of HIV-1 latency by T-cell activation. |
| Q37423506 | Regulation of HIV-1 transcription at 3% versus 21% oxygen concentration |
| Q38613277 | Regulation of Innate Immune Responses by Bovine Herpesvirus 1 and Infected Cell Protein 0 (bICP0). |
| Q41880147 | Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. |
| Q34090863 | Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency |
| Q24797263 | SIRT1 regulates HIV transcription via Tat deacetylation |
| Q35227888 | Selective HDAC inhibition for the disruption of latent HIV-1 infection |
| Q34482017 | Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB |
| Q36553940 | Selective targeting of the repressive transcription factors YY1 and cMyc to disrupt quiescent human immunodeficiency viruses |
| Q39262129 | Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma |
| Q47224816 | Structural basis of gene regulation by the Grainyhead/CP2 transcription factor family |
| Q35358497 | Sulfonation pathway inhibitors block reactivation of latent HIV-1. |
| Q42100247 | Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency |
| Q34349201 | Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies |
| Q28213125 | Targeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrrole-imidazole polyamides |
| Q54210140 | Targeting the Latent Reservoir for HIV-1. |
| Q64107839 | Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat |
| Q38024618 | The BAF complex and HIV latency |
| Q91661378 | The Per-1 Short Isoform Inhibits de novo HIV-1 Transcription in Resting CD4+ T-cells |
| Q92188718 | The Role of Macrophages in HIV-1 Persistence and Pathogenesis |
| Q24336893 | The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter |
| Q91871522 | The Two Sides of YY1 in Cancer: A Friend and a Foe |
| Q24291697 | The bovine herpesvirus 1 immediate-early protein (bICP0) associates with histone deacetylase 1 to activate transcription |
| Q37407598 | The challenge of finding a cure for HIV infection |
| Q36906001 | The effects of cocaine on HIV transcription |
| Q36501927 | The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro |
| Q42207197 | The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events. |
| Q28251761 | The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention |
| Q24613885 | The transcription factor LSF: a novel oncogene for hepatocellular carcinoma |
| Q38301274 | The transcriptional regulator Yin Yang 1 activates the myelin PLP gene |
| Q36001865 | The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention |
| Q37626634 | Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitors |
| Q37483136 | Transcription factor YY1 associates with pericentromeric gamma-satellite DNA in cycling but not in quiescent (G0) cells |
| Q34755987 | Transcription factor YY1 binds to the murine beta interferon promoter and regulates its transcriptional capacity with a dual activator/repressor role. |
| Q41860319 | Transcription factor YY1 interacts with retroviral integrases and facilitates integration of moloney murine leukemia virus cDNA into the host chromosomes |
| Q33565167 | Transcriptional Gene Silencing (TGS) via the RNAi Machinery in HIV-1 Infections |
| Q24307916 | Transcriptional repression of human immunodeficiency virus type 1 by AP-4 |
| Q36422209 | Unbiased proteomic analysis of proteins interacting with the HIV-1 5'LTR sequence: role of the transcription factor Meis |
| Q39160623 | Underlying mechanisms of HIV-1 latency. |
| Q37388295 | Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ T cells |
| Q36943080 | Up-regulation of activating transcription factor-5 suppresses SAP expression to activate T cells in hemophagocytic syndrome associated with Epstein-Barr virus infection and immune disorders |
| Q37393518 | Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells |
| Q35026881 | Viral-host interactions that control HIV-1 transcriptional elongation |
| Q37364293 | Waking up the sleepers: HIV latency and reactivation |
| Q24646624 | YY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infection |
| Q33400343 | Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcription |
| Q35676877 | Yin Yang 1 is a critical repressor of matrix metalloproteinase-9 expression in brain neurons. |
| Q43785519 | Yin-Yang 1 activates interleukin-4 gene expression in T cells. |
Search more.